| Tumour-derived exosome SNHG17 induced by oestrogen contributes to ovarian cancer progression via the CCL13-CCR2-M2 macrophage axis. | Tumour-derived exosome SNHG17 induced by oestrogen contributes to ovarian cancer progression via the CCL13-CCR2-M2 macrophage axis.
Liang H, Geng S, Wang Y, Fang Q, Xin Y, Li Y., Free PMC Article | 05/24/2024 |
| SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma. | SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma.
Lin J, Liu Y, Liu P, Qi W, Liu J, He X, Liu Q, Liu Z, Yin J, Lin J, Bao H, Lin J., Free PMC Article | 12/20/2023 |
| Identification of two novel lipid metabolism-related long non-coding RNAs (SNHG17 and LINC00837) as potential signatures for osteosarcoma prognosis and precise treatment. | Identification of two novel lipid metabolism-related long non-coding RNAs (SNHG17 and LINC00837) as potential signatures for osteosarcoma prognosis and precise treatment.
Tang Z, Feng H, Shu L, Guo M, Qi B, Pu L, Shi H, Ren J, Li C., Free PMC Article | 05/30/2023 |
| Lactobacillus rhamnosus GG ameliorates radiation-induced lung fibrosis via lncRNASNHG17/PTBP1/NICD axis modulation. | Lactobacillus rhamnosus GG ameliorates radiation-induced lung fibrosis via lncRNASNHG17/PTBP1/NICD axis modulation.
Ju Z, Pan H, Qu C, Xiao L, Zhou M, Wang Y, Luo J, Shen L, Zhou P, Huang R., Free PMC Article | 01/21/2023 |
| Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition. | Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
Huang G, Cai G, Hu D, Li J, Xu Q, Chen Z, Xu B. | 12/24/2022 |
| Silencing of lncRNA SNHG17 inhibits the tumorigenesis of epithelial ovarian cancer through regulation of miR-485-5p/AKT1 axis. | Silencing of lncRNA SNHG17 inhibits the tumorigenesis of epithelial ovarian cancer through regulation of miR-485-5p/AKT1 axis.
Wang W, Yu S, Li W, Hu H, Zou G. | 12/10/2022 |
| Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network. | Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.
Li J, Yu H, Yao J, Jiang Z, Li Z, Cui X., Free PMC Article | 07/30/2022 |
| LncRNA SNHG17 predicts poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma. | LncRNA SNHG17 predicts poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma.
Zhu XM, Li L, Ren LL, Du L, Wang YM. | 03/5/2022 |
| LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation. | LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation.
Liu JY, Chen YJ, Feng HH, Chen ZL, Wang YL, Yang JE, Zhuang SM., Free PMC Article | 02/5/2022 |
| LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma. | LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma.
Chen W, Wang L, Li X, Zhao C, Shi L, Zhao H, Huang C., Free PMC Article | 01/29/2022 |
| SNHG17, as an EMT-related lncRNA, promotes the expression of c-Myc by binding to c-Jun in esophageal squamous cell carcinoma. | SNHG17, as an EMT-related lncRNA, promotes the expression of c-Myc by binding to c-Jun in esophageal squamous cell carcinoma.
Shen S, Liang J, Liang X, Wang G, Feng B, Guo W, Guo Y, Dong Z., Free PMC Article | 01/15/2022 |
| SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression. | SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression.
Liu X, Zhang B, Jia Y, Fu M., Free PMC Article | 12/4/2021 |
| LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis. | LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis.
Tong F, Guo J, Miao Z, Li Z. | 10/23/2021 |
| LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma. | LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma.
Luo Y, Lin J, Zhang J, Song Z, Zheng D, Chen F, Zhuang X, Li A, Liu X., Free PMC Article | 10/23/2021 |
| Long non-coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR-23b-3p/ZHX1 axis. | Long non-coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR-23b-3p/ZHX1 axis.
Ge BH, Li GC. | 09/4/2021 |
| LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1. | LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1.
Zheng ZJ, Liu Y, Wang HJ, Pang WW, Wang Y. | 05/8/2021 |
| SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis. | SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis.
Du F, Hou Q., Free PMC Article | 04/17/2021 |
| SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p. | SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p.
Li W, Zheng Y, Mao B, Wang F, Zhong Y, Cheng D. | 03/28/2021 |
| H. pylori infection alters repair of DNA double-strand breaks via SNHG17. | H. pylori infection alters repair of DNA double-strand breaks via SNHG17.
Han T, Jing X, Bao J, Zhao L, Zhang A, Miao R, Guo H, Zhou B, Zhang S, Sun J, Shi J., Free PMC Article | 02/6/2021 |
| LncRNA SNHG17 acts as a ceRNA of miR-324-3p to contribute the progression of osteosarcoma. | LncRNA SNHG17 acts as a ceRNA of miR-324-3p to contribute the progression of osteosarcoma.
Zhang YT, Yang GY. | 11/21/2020 |
| STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway. | STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H, Liu R, Sun X. | 10/10/2020 |
| findings indicated that SNHG17 was a novel molecule involved in Gastric Cancer progression, providing a potential prognostic biomarker for GC patients. | The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer.
Chen LL, He J, Qiu XT, Yu J, Wang ZM. | 07/18/2020 |
| SNHG17 expression is negatively correlated with high-density lipoprotein cholesterol in type 2 diabetes mellitus. | Deregulation of long noncoding RNA SNHG17 and TTC28-AS1 is associated with type 2 diabetes mellitus.
Mohamadi M, Ghaedi H, Kazerouni F, Erfanian Omidvar M, Kalbasi S, Shanaki M, Miraalamy G, Rahimipour A. | 06/13/2020 |
| SNHG17 acting as a noncoding oncogene in gastric cancer tumorigenesis, promoting gastric cancer progression by epigenetically silencing of p15 and p57. | LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
Zhang G, Xu Y, Wang S, Gong Z, Zou C, Zhang H, Ma G, Zhang W, Jiang P. | 03/21/2020 |
| lncRNA SNHG17 is upregulated in CRC tissues and correlates with poor prognosis, thereby potentially representing an unfavourable prognostic factor for CRC patients. | Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
Ma Z, Gu S, Song M, Yan C, Hui B, Ji H, Wang J, Zhang J, Wang K, Zhao Q. | 06/9/2018 |